ENO1 and gastric cancer: Qian X et al. by analyzing gastric cancers have found that elevated levels of ENO-1 proteins (or downregulation of ENO-1 targeting miR-22) were associated with shorter overall survival and ENO-1 is a novel biomarker to predict drug resistance and overall prognosis in gastric cancer.